Hanahan D.,Weinberg R.A. .2011 .Hallmarks of cancer: the next generation. Cell, 144(5) : 646-74.
Hassan M. .2014 .Apoptosis and molecular targeting therapy in cancer. Biomed Res Int, : 150845.
Thun M.J. .2010 .The global burden of cancer: priorities for prevention. Carcinogenesis, 31(1) : 100-10.
Salehiniya H. .2016 .A Population-based Cancer Registries Study (northern Iran). Caspian J Intern Med, 7(1) : 25-30.
Rojas K.,Stuckey A.,Factors Risk .2016 .Breast Cancer Epidemiology. Clin Obstet Gynecol, 59(4) : 651-672.
Jin X.,Mu P. .2015 .Targeting Breast Cancer Metastasis. Breast Cancer (Auckl), 9(Suppl 1) : 23-34.
Youlden D.R. .2014 .Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med, 11(2) : 101-15.
Miller T.W.,Balko J.M.,Arteaga C.L. .2011 .- kinase and antiestrogen resistance in breast cancer. J Clin Oncol, 29(33) : 4452-61.
Klint A. .2010 .Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. , 49(5) : 578-607.
Beger H.G. .1999 .Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg, 23(9) : 946-9.
Siegel C.,Desantis C.,Jemal A. .2014 .and. , 64(2) : 104-17.
Ferlay J. .2015 .Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136(5) : E359-86.
Rahib L. .2014 .Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res, 74(11) : 2913-21.
Dorai B.B.,Aggarwal B.B. .2004 .Role of chemopreventive agents in cancer therapy. Cancer Lett, 215(2) : 129-40.
Kaur C.,Agarwal R.,Agarwal R. .2009 .Anticancer and cancer chemopreventive potential of grape seed extract and other grapebased products. J Nutr, 139(9) : 1806S-12S.
Kolonel L.N. .2000 .Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev, 9(8) : 795-804.
Surh Y.J. .2003 .Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer, 3(10) : 768-80.
Srinivasan K. .2014 .Antioxidant potential of spices and their active constituents. Crit Rev Food Sci Nutr, 54(3) : 352-72.
Shukla Y.,Singh M. .2007 .Cancer preventive properties of ginger: a brief review. Food Chem Toxicol, 45(5) : 683-90.
Maghbooli M. .2014 .Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine. Phytother Res, 28(3) : 412-5.
Mashhadi N.S. .2013 .Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: review of current evidence. Int J Prev Med, 4(Suppl 1) : S36-42.
Raal A. .2013 .Complementary treatment of the common cold and flu with medicinal plants--results from two samples of pharmacy customers in Estonia. PLoS One, 8(3) : e58642.
Al-Nahain A.,Jahan R.,Rahmatullah M. .2014 .Zingiber officinale: A Potential Plant against Rheumatoid Arthritis. , : 159089.
Koo S.W.,M.K. Lim K.W.,Lee K.W. .2015 .Immunomodulatory effects of zingiber officinale in cyclophosphamide-induced immunosuppress mice. Journal of Veterinary Clinics, 32 : 56-61.
Seeram N.P. .2004 .Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem, 52(9) : 2512-7.
Nigam N. .2010 .Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis. Cancer Chemother Pharmacol, 65(4) : 687-96.
Seemann S. .2004 .The tumor suppressor gene TP53: implications for cancer management and therapy. Crit Rev Clin Lab Sci, 41(5- 6) : 551-83.
Willis A.C.,Chen X. .2002 .The promise and obstacle of p53 as a cancer therapeutic agent. Curr Mol Med, 2(4) : 329-45.
Xin Y. .2017 .Recent progress on nanoparticle-based drug delivery systems for cancer therapy. Cancer Biol Med, 14(3) : 228-241.
Elmore S.,Apoptosis : .2007 .a review of programmed cell death. Toxicol Pathol, 35(4) : 495-516.
Bertheau P. .2013 .p53 in breast cancer subtypes and new insights into response to chemotherapy. Breast, 22(Suppl 2) : S27-9.
Yin S.Y. .2013 .Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Alternat Med, : 302426.
Babasheikhali Rahimi,Rahgozar S.,Mohammadi M. .2019 .Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells. J Cancer Res Clin Oncol, 145(8) : 1987-1998.
Prasad S.,Tyagi A.K. .2015 .Ginger and its constituents: role in prevention and treatment of gastrointestinal cancer. Gastroenterol Res Pract, : 142979.
Karna P. .2012 .Benefits of whole ginger extract in prostate cancer. Br J Nutr, 107(4) : 473-84.
Pashaei-Asl R. .2017 .. The Inhibitory Effect of Ginger Extract on Ovarian Cancer Cell Line; Application of Systems Biology. Adv Pharm Bull, 7(2) : 241-249.
Hessien M. .2012 .Growth inhibition of human non-small lung cancer cells h460 by green tea and ginger polyphenols. Anticancer Agents Med Chem, 12(4) : 383-90.
Sreedhar A.,Li J.,Zhao Y. .2018 .Next-Gen Therapeutics for Skin Cancer: Nutraceuticals. , 70(5) : 697-709.
Nelson ,M.B. Kastan .1994 .DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol, 14(3) : 1815-23.
Zhang S. .2012 .Zerumbone, a Southeast Asian Ginger Sesquiterpene, Induced Apoptosis of Pancreatic Carcinoma Cells through p53 Signaling Pathway. Evid Based Complement Alternat Med, : 936030.
Nalbantsoy A. .2008 .Antimicrobial and Cytotoxic Activities of Zingiber officinalis Extracts. Journal of Pharmacy and Pharmaceutical Sciences, 33 : 78-85.
Park Y.J. .2006 .-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med, 47(5) : 688-97.
El-Ashmawy N.E. .2018 .Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms. Eur J Nutr, 57(3) : 981-989.
Hostanska K. .2004 .Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res Treat, 84(2) : 151-60.
Habib S.H. .2008 .Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics (Sao Paulo), 63(6) : 807-13.
Levine M.E. .2008 .Protein and ginger for the treatment of chemotherapy-induced delayed nausea. J Altern Complement Med, 14(5) : 545-51.
Citronberg J. .2013 .Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prev Res (Phila), 6(4) : 271-81.
Sung B. .2008 .Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells. Cancer Res, 68(21) : 8938-44.
Elbendary A.A. .1996 .Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res, 2(9) : 1571-5.
Elkady A.I. .2012 .Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale. J Biomed Biotechnol, : 614356.
Gaus K. .2009 .Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected with cagAHelicobacter pylori. Pharm Biol, 47(1) : 92-98.
Oyagbemi A.A.,Saba A.B.,O.I. Azeez A.B. . .- gingerol: Its potential roles in cancer chemoprevention. , : .